G1 Therapeutics, Inc. Annual Depreciation in USD from 2015 to 2022

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
G1 Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2015 to 2022.
  • G1 Therapeutics, Inc. Depreciation for the quarter ending June 30, 2024 was $121K, a 6.92% decline year-over-year.
  • G1 Therapeutics, Inc. Depreciation for the twelve months ending June 30, 2024 was $881K, a 63.8% increase year-over-year.
  • G1 Therapeutics, Inc. annual Depreciation for 2022 was $530K, a 13% increase from 2021.
  • G1 Therapeutics, Inc. annual Depreciation for 2021 was $469K, a 19.4% decline from 2020.
  • G1 Therapeutics, Inc. annual Depreciation for 2020 was $582K, a 63.5% increase from 2019.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $530K +$61K +13% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 $469K -$113K -19.4% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 $582K +$226K +63.5% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 $356K +$181K +103% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-23
2018 $175K +$86K +96.6% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-24
2017 $89K +$22K +32.8% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-26
2016 $67K +$25K +59.5% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 $42K Jan 1, 2015 Dec 31, 2015 10-K 2018-02-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.